Acute Responses of Active Video Games and Traditional Exercise Program in in Patients With Pulmonary Hypertension - Trial NCT05901168
Access comprehensive clinical trial information for NCT05901168 through Pure Global AI's free database. This phase not specified trial is sponsored by Dokuz Eylul University and is currently Not yet recruiting. The study focuses on Pulmonary Hypertension. Target enrollment is 20 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Dokuz Eylul University
Timeline & Enrollment
N/A
Aug 01, 2023
Mar 01, 2024
Primary Outcome
Exercise load end heart rate,Exercise load end blood pressure
Summary
At least 20 volunteers with a diagnosis of Pulmonary Hypertension in the Department of
 Cardiology of Dokuz Eylul University and who meet the criteria for follow-up and inclusion
 will participate in the study. The aim of this study is to examine the acute effects of
 active video games compared to traditional exercise and the effects on energy expenditure and
 enjoyment in PD patients. Demographic and clinical information of the participants will be
 questioned. Active video games and home-based exercise sessions will be held randomly/by the
 same person with a break of at least 1 day in 1 week, lasting 20 minutes. Heart rate, blood
 pressure, shortness of breath and oxygen saturation will be measured before and after the
 sessions. In addition, energy expenditure, heart rate, perceived exertion, shortness of
 breath and oxygen saturation will be recorded during the sessions. In addition, arterial
 stiffness will be evaluated with a non-invasive device. At the end of the sessions, whether
 people like active video games or not will be questioned with a 10-point Likert-type scale.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05901168
Non-Device Trial

